73 results
424B5
BLRX
BioLineRx Ltd.
1 Apr 24
Prospectus supplement for primary offering
10:30am
and subsequent deposit thereof with the depositary and delivery of ADSs.
S - 11
PLAN OF DISTRIBUTION
Pursuant to an engagement agreement, we have engaged … and warrants pursuant to this prospectus supplement and accompanying prospectus. Under the terms of the engagement agreement, the placement agent has agreed
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
engagement regarding such matters. In addition, new sustainability rules and regulations have been adopted and may continue to be introduced in various … and recommending the engagement, compensation or termination of engagement of our independent registered public accounting firm to our board of directors
6-K
EX-99
BLRX
BioLineRx Ltd.
30 Aug 23
Current report (foreign)
6:45am
, and with the understanding that on the basis of such authorization and engagement by HS Tech, Gloria Biosciences will conduct all of the activities under the License … under this Agreement to any other third party or any replacement or adjustment of HS Tech’s engagement or authorization of Gloria Biosciences
6-K
EX-10.3
a3oz7tzv9p7ftw
21 Sep 22
Current report (foreign)
8:00am
424B5
l71iw56xidens53e
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
uwreei5zk86
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
u6u7nr66aigu3p7
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
qetod6jemwwy1ze 7p
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
vodrvolx
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
95ypsumzgcynz8
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
glriw
19 Jan 21
Prospectus supplement for primary offering
5:00pm
6-K
EX-10.1
rml5b pe510aawoo
25 Sep 20
Current report (foreign)
4:33pm
424B5
piki94c3
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
8m23s p23
3 Jun 20
Current report (foreign)
8:30am
424B5
kv2bki9ob08 vukuv
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-10.3
k4t65vsnf
28 May 20
Current report (foreign)
11:56am